Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Neumora Therapeutics, Inc.

Clinical trials sponsored by Neumora Therapeutics, Inc., explained in plain language.

Neumora Therapeutics, Inc. NMRA NASDAQ

Biotech developing brain disease therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 5

New depression drug tested for long-term safety in 1,000 patients

Disease control Ongoing

This study looks at the long-term safety and effectiveness of an experimental drug called NMRA-335140 for people with major depressive disorder. About 1,000 adults who completed earlier studies of this drug will take it for 52 weeks. Researchers will track side effects and change…

Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC